WO2001057239A3 - Reagent test strip for analyte determination - Google Patents

Reagent test strip for analyte determination Download PDF

Info

Publication number
WO2001057239A3
WO2001057239A3 PCT/US2001/002547 US0102547W WO0157239A3 WO 2001057239 A3 WO2001057239 A3 WO 2001057239A3 US 0102547 W US0102547 W US 0102547W WO 0157239 A3 WO0157239 A3 WO 0157239A3
Authority
WO
WIPO (PCT)
Prior art keywords
reagent test
test strips
subject
test strip
methods
Prior art date
Application number
PCT/US2001/002547
Other languages
French (fr)
Other versions
WO2001057239A2 (en
Inventor
Adva Yani
Paing C Huang
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Priority to EP01905073A priority Critical patent/EP1252515A2/en
Priority to KR1020027009675A priority patent/KR20020073190A/en
Priority to JP2001555862A priority patent/JP2003521246A/en
Priority to MXPA02005798A priority patent/MXPA02005798A/en
Priority to CA002388283A priority patent/CA2388283A1/en
Priority to IL14966501A priority patent/IL149665A0/en
Priority to AU32991/01A priority patent/AU783251B2/en
Priority to PL01358137A priority patent/PL358137A1/en
Publication of WO2001057239A2 publication Critical patent/WO2001057239A2/en
Publication of WO2001057239A3 publication Critical patent/WO2001057239A3/en
Priority to HK03101792.5A priority patent/HK1049699A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Abstract

Reagent test strips and methods for their use in the determination of the concentration of an analyte, e.g. glucose, in a physiological sample, are provided. The subject reagent test strips include one or more members of an analyte oxidation signal producing system and at least one hemolyzing agent. The subject reagent test strips and methods are particularly suited for use in the detection of blood glucose concentrations. Also provided are kits that include the subject test strips for use in practicing the subject methods.
PCT/US2001/002547 2000-02-02 2001-01-25 Reagent test strip for analyte determination WO2001057239A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
EP01905073A EP1252515A2 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
KR1020027009675A KR20020073190A (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
JP2001555862A JP2003521246A (en) 2000-02-02 2001-01-25 Reagent test strips for analyte measurement
MXPA02005798A MXPA02005798A (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination.
CA002388283A CA2388283A1 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
IL14966501A IL149665A0 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
AU32991/01A AU783251B2 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
PL01358137A PL358137A1 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination
HK03101792.5A HK1049699A1 (en) 2000-02-02 2003-03-12 Reagent test strip for analyte determination

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/497,631 US6485923B1 (en) 2000-02-02 2000-02-02 Reagent test strip for analyte determination having hemolyzing agent
US09/497,631 2000-02-02

Publications (2)

Publication Number Publication Date
WO2001057239A2 WO2001057239A2 (en) 2001-08-09
WO2001057239A3 true WO2001057239A3 (en) 2002-03-14

Family

ID=23977641

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002547 WO2001057239A2 (en) 2000-02-02 2001-01-25 Reagent test strip for analyte determination

Country Status (16)

Country Link
US (3) US6485923B1 (en)
EP (1) EP1252515A2 (en)
JP (1) JP2003521246A (en)
KR (1) KR20020073190A (en)
CN (1) CN1207393C (en)
AR (1) AR027346A1 (en)
AU (1) AU783251B2 (en)
CA (1) CA2388283A1 (en)
CZ (1) CZ20022945A3 (en)
HK (1) HK1049699A1 (en)
IL (1) IL149665A0 (en)
MX (1) MXPA02005798A (en)
MY (1) MY133942A (en)
PL (1) PL358137A1 (en)
RU (1) RU2002113055A (en)
WO (1) WO2001057239A2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US8071384B2 (en) 1997-12-22 2011-12-06 Roche Diagnostics Operations, Inc. Control and calibration solutions and methods for their use
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US20050103624A1 (en) 1999-10-04 2005-05-19 Bhullar Raghbir S. Biosensor and method of making
US6485923B1 (en) * 2000-02-02 2002-11-26 Lifescan, Inc. Reagent test strip for analyte determination having hemolyzing agent
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
DE60238119D1 (en) 2001-06-12 2010-12-09 Pelikan Technologies Inc ELECTRIC ACTUATOR ELEMENT FOR A LANZETTE
EP1404232B1 (en) * 2001-06-12 2009-12-02 Pelikan Technologies Inc. Blood sampling apparatus and method
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US7749174B2 (en) 2001-06-12 2010-07-06 Pelikan Technologies, Inc. Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge
US7699791B2 (en) * 2001-06-12 2010-04-20 Pelikan Technologies, Inc. Method and apparatus for improving success rate of blood yield from a fingerstick
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
CA2419213C (en) * 2002-03-07 2011-06-21 Bayer Healthcare Llc Improved electrical sensor
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7713214B2 (en) 2002-04-19 2010-05-11 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
US7481776B2 (en) * 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8372016B2 (en) 2002-04-19 2013-02-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7485128B2 (en) * 2002-04-19 2009-02-03 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7563232B2 (en) * 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) * 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7410468B2 (en) * 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7141058B2 (en) * 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US6759190B2 (en) 2002-06-15 2004-07-06 Acon Laboratories, Inc. Test strip for detection of analyte and methods of use
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7811231B2 (en) 2002-12-31 2010-10-12 Abbott Diabetes Care Inc. Continuous glucose monitoring system and methods of use
WO2004060174A2 (en) * 2002-12-31 2004-07-22 Pelikan Technologies Inc. Method and apparatus for loading penetrating members
EP1447665B1 (en) 2003-02-11 2016-06-29 Bayer HealthCare LLC Method for reducing effect of hematocrit on measurement of an analyte in whole blood
US8262614B2 (en) 2003-05-30 2012-09-11 Pelikan Technologies, Inc. Method and apparatus for fluid injection
US7850621B2 (en) 2003-06-06 2010-12-14 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2005006939A2 (en) * 2003-06-11 2005-01-27 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US7718439B2 (en) 2003-06-20 2010-05-18 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8148164B2 (en) 2003-06-20 2012-04-03 Roche Diagnostics Operations, Inc. System and method for determining the concentration of an analyte in a sample fluid
KR100785670B1 (en) 2003-06-20 2007-12-14 에프. 호프만-라 로슈 아게 Method and reagent for producing narrow, homogenous reagent strips
US7452457B2 (en) 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7645373B2 (en) 2003-06-20 2010-01-12 Roche Diagnostic Operations, Inc. System and method for coding information on a biosensor test strip
US7645421B2 (en) 2003-06-20 2010-01-12 Roche Diagnostics Operations, Inc. System and method for coding information on a biosensor test strip
US8071030B2 (en) 2003-06-20 2011-12-06 Roche Diagnostics Operations, Inc. Test strip with flared sample receiving chamber
US8206565B2 (en) 2003-06-20 2012-06-26 Roche Diagnostics Operation, Inc. System and method for coding information on a biosensor test strip
US8679853B2 (en) 2003-06-20 2014-03-25 Roche Diagnostics Operations, Inc. Biosensor with laser-sealed capillary space and method of making
US8058077B2 (en) 2003-06-20 2011-11-15 Roche Diagnostics Operations, Inc. Method for coding information on a biosensor test strip
WO2005033659A2 (en) 2003-09-29 2005-04-14 Pelikan Technologies, Inc. Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US7365720B2 (en) * 2003-12-23 2008-04-29 Barco N.V. Colour calibration of emissive display devices
US8668656B2 (en) 2003-12-31 2014-03-11 Sanofi-Aventis Deutschland Gmbh Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
CA2553632A1 (en) 2004-02-06 2005-08-25 Bayer Healthcare Llc Oxidizable species as an internal reference for biosensors and method of use
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
BRPI0510779A (en) 2004-05-14 2007-11-20 Bayer Healthcare Llc methods for performing hematocrit adjustment in assays and devices for same
WO2006011062A2 (en) 2004-05-20 2006-02-02 Albatros Technologies Gmbh & Co. Kg Printable hydrogel for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
BRPI0613592A2 (en) 2005-07-20 2011-01-18 Bayer Healthcare Llc port-connected amperometry
EP3483598A1 (en) 2005-09-30 2019-05-15 Ascensia Diabetes Care Holdings AG Gated voltammetry
US20100145158A1 (en) * 2005-10-06 2010-06-10 Hamilton Scott E Pod Connected Data Monitoring System
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7993512B2 (en) 2006-07-11 2011-08-09 Bayer Healthcare, Llc Electrochemical test sensor
WO2009076271A2 (en) * 2007-12-10 2009-06-18 Bayer Healthcare Llc Wear-resistant electrochemical test sensor and method of forming the same
WO2009076302A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc Control markers for auto-detection of control solution and methods of use
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
US8883439B2 (en) 2008-07-23 2014-11-11 Nippon Kayaku Kabushiki Kaisha Blood component measurement method utilizing hemolyzed whole blood, and kit for the method
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
EP2542887B1 (en) * 2010-03-01 2013-06-19 System Biologie AG Test strip for the detection of equol
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
TWI414432B (en) * 2011-07-08 2013-11-11 Microjet Technology Co Ltd Manufacturing method of conductive layer of blood glucose test strips
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
EP3581925A1 (en) 2013-03-14 2019-12-18 Instrumentation Laboratory Company Whole blood hemolysis sensor
US9121050B2 (en) 2013-03-15 2015-09-01 American Sterilizer Company Non-enzyme based detection method for electronic monitoring of biological indicator
US8858884B2 (en) 2013-03-15 2014-10-14 American Sterilizer Company Coupled enzyme-based method for electronic monitoring of biological indicator
CN103630535A (en) * 2013-12-03 2014-03-12 上海科华生物工程股份有限公司 Dry chemical test paper for quantitatively determining content of human blood albumin
CN106574929B (en) 2014-07-25 2019-08-09 贝克顿·迪金森公司 Analyte testing item test and for its implement test-strips and kit
CN105954270A (en) * 2016-04-27 2016-09-21 樊福好 Solution for evaluating glucose metabolism based on sialology method and evaluation method thereof
US20180295158A1 (en) * 2017-04-05 2018-10-11 Microsoft Technology Licensing, Llc Displaying group expressions for teleconference sessions
CN115655829A (en) * 2018-08-06 2023-01-31 中国人民解放军总医院第五医学中心 Improved hemolysin, application thereof and method for special hemolysin and cell grouping counting for flow cytometry detection
KR102136193B1 (en) * 2019-10-28 2020-07-21 주식회사 원드롭 Strip for measuring hemoglobin concentration
CN112014573B (en) * 2020-08-25 2023-08-08 武汉生之源生物科技股份有限公司 Preparation method of high-sensitivity assay kit for troponin I in human whole blood sample and kit
WO2023112442A1 (en) * 2021-12-13 2023-06-22 テルモ株式会社 Biological component concentration measurement reagent, measurement method, and sensor

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424355A1 (en) * 1983-07-06 1985-01-17 Kabushiki Kaisha Kyoto Daiichi Kagaku, Kyoto Analytical aid with a plurality of layers combined to form a unit, and method for analysing a liquid sample
DE4229477A1 (en) * 1992-09-03 1994-03-10 Miles Inc Prepn. of a highly porous membrane - by selective removal of polymers; useful as testing strips in urine analysis
EP0695936A2 (en) * 1994-08-03 1996-02-07 TOA MEDICAL ELECTRONICS CO., Ltd. A method for classifying and counting leukocytes
EP0708335A2 (en) * 1994-10-19 1996-04-24 Fuji Photo Film Co., Ltd. Dry analytical element containing ampholyte
US5705357A (en) * 1994-08-29 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Chemiluminescent reagent and assay using a substituted acetanilide for light generation
EP0840124A2 (en) * 1996-10-31 1998-05-06 Kyoto Daiichi Kagaku Co., Ltd. Analytical element with dry reagent
US5891731A (en) * 1996-04-12 1999-04-06 Toa Medical Electronics Co., Ltd. Reagent for measuring reticulocytes and a method of measuring them

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE708335C (en) 1939-03-26 1941-07-18 Gertrud Recknagel Duvet holder, especially for cots, consisting of a belt that can be folded around the mattress
DE695936C (en) 1939-03-28 1940-09-06 Wilhelm Stoehr Maschinenfabrik
DE840124C (en) 1942-10-23 1952-05-29 Cfcmug Arrangement on cathode ray tubes
DE2850603A1 (en) * 1978-11-22 1980-06-19 Merck Patent Gmbh HAEMOLYSIS SOLUTION AND METHOD FOR HAEMOLYSING BLOOD
DE3303098A1 (en) * 1983-01-31 1984-08-02 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD AND REAGENT FOR DETERMINING GLUCOSE IN HAEMOLYSED BLOOD
JPS62296987A (en) 1986-08-06 1987-12-24 Amada Co Ltd Laser beam machine
US4935346A (en) 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
SE466157B (en) 1989-04-25 1992-01-07 Migrata Uk Ltd DETERMINED TO DETERMINE THE GLUCOSE CONTENT OF WHOLE BLOOD AND DISPOSABLE BEFORE THIS
SE466158B (en) 1989-04-25 1992-01-07 Migrata Uk Ltd METHOD OF ANALYSIS FOR GLUCOSE DETERMINATION IN WHOLE BLOOD
JP2614124B2 (en) 1989-12-08 1997-05-28 富士写真フイルム株式会社 Integrated multilayer analytical element
JP3064409B2 (en) 1990-11-30 2000-07-12 株式会社日立製作所 Holding device and semiconductor manufacturing apparatus using the same
DE4206932A1 (en) * 1992-03-05 1993-09-09 Boehringer Mannheim Gmbh IMMUNOLOGICAL METHOD FOR DETERMINING A HAEMOGLOBIN DERIVATIVE
GR1002549B (en) 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
US5843691A (en) 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
AU666821B2 (en) 1993-08-05 1996-02-22 Bayer Corporation Analyte detection device and process
US5695949A (en) * 1995-04-07 1997-12-09 Lxn Corp. Combined assay for current glucose level and intermediate or long-term glycemic control
AU722471B2 (en) 1995-10-17 2000-08-03 Lifescan, Inc. Blood glucose strip having reduced sensitivity to hematocrit
US5753452A (en) 1996-04-04 1998-05-19 Lifescan, Inc. Reagent test strip for blood glucose determination
IL120587A (en) 1996-04-04 2000-10-31 Lifescan Inc Reagent test strip for determination of blood glucose
US6485923B1 (en) * 2000-02-02 2002-11-26 Lifescan, Inc. Reagent test strip for analyte determination having hemolyzing agent

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424355A1 (en) * 1983-07-06 1985-01-17 Kabushiki Kaisha Kyoto Daiichi Kagaku, Kyoto Analytical aid with a plurality of layers combined to form a unit, and method for analysing a liquid sample
DE4229477A1 (en) * 1992-09-03 1994-03-10 Miles Inc Prepn. of a highly porous membrane - by selective removal of polymers; useful as testing strips in urine analysis
EP0695936A2 (en) * 1994-08-03 1996-02-07 TOA MEDICAL ELECTRONICS CO., Ltd. A method for classifying and counting leukocytes
US5705357A (en) * 1994-08-29 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Chemiluminescent reagent and assay using a substituted acetanilide for light generation
EP0708335A2 (en) * 1994-10-19 1996-04-24 Fuji Photo Film Co., Ltd. Dry analytical element containing ampholyte
US5891731A (en) * 1996-04-12 1999-04-06 Toa Medical Electronics Co., Ltd. Reagent for measuring reticulocytes and a method of measuring them
EP0840124A2 (en) * 1996-10-31 1998-05-06 Kyoto Daiichi Kagaku Co., Ltd. Analytical element with dry reagent

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9014773B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8880137B2 (en) 1998-04-30 2014-11-04 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326714B2 (en) 1998-04-30 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9072477B2 (en) 1998-04-30 2015-07-07 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8840553B2 (en) 1998-04-30 2014-09-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011331B2 (en) 1998-04-30 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9498159B2 (en) 2001-01-02 2016-11-22 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9011332B2 (en) 2001-01-02 2015-04-21 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9477811B2 (en) 2001-04-02 2016-10-25 Abbott Diabetes Care Inc. Blood glucose tracking apparatus and methods
US8920319B2 (en) 2005-11-01 2014-12-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8915850B2 (en) 2005-11-01 2014-12-23 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9326716B2 (en) 2005-11-01 2016-05-03 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9323898B2 (en) 2005-11-04 2016-04-26 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US8933664B2 (en) 2006-03-31 2015-01-13 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9380971B2 (en) 2006-03-31 2016-07-05 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US9095290B2 (en) 2007-03-01 2015-08-04 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US9035767B2 (en) 2007-05-08 2015-05-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9314198B2 (en) 2007-05-08 2016-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9177456B2 (en) 2007-05-08 2015-11-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9000929B2 (en) 2007-05-08 2015-04-07 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US9574914B2 (en) 2007-05-08 2017-02-21 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise

Also Published As

Publication number Publication date
CN1394281A (en) 2003-01-29
AU783251B2 (en) 2005-10-06
US20020192733A1 (en) 2002-12-19
MXPA02005798A (en) 2003-10-14
US20050095659A1 (en) 2005-05-05
MY133942A (en) 2007-11-30
AR027346A1 (en) 2003-03-26
AU3299101A (en) 2001-08-14
PL358137A1 (en) 2004-08-09
WO2001057239A2 (en) 2001-08-09
IL149665A0 (en) 2002-11-10
HK1049699A1 (en) 2003-05-23
US6998248B2 (en) 2006-02-14
US6485923B1 (en) 2002-11-26
KR20020073190A (en) 2002-09-19
JP2003521246A (en) 2003-07-15
RU2002113055A (en) 2004-08-20
CA2388283A1 (en) 2001-08-09
CN1207393C (en) 2005-06-22
US6989243B2 (en) 2006-01-24
EP1252515A2 (en) 2002-10-30
CZ20022945A3 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
WO2001057239A3 (en) Reagent test strip for analyte determination
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
CA2330629A1 (en) Method and device for predicting physiological values
MXPA02011478A (en) Stabilized tetrazolium-phenazine reagent compositions and methods for using the same.
WO2004063713A3 (en) Non-invasive determination of direction and rate of change of an analyte
GB2321967A (en) Opaque reaction matrix for the analysis of whole blood
WO2003008933A3 (en) Test strip for a lateral flow assay
CA2435550A1 (en) System for monitoring the concentration of analytes in body fluids
ATE279726T1 (en) BUAL-DIRECTIONAL TRANSVERSAL FLOW TEST STRIPS AND METHODS
CA2332112A1 (en) Monitoring of physiological analytes
PL355356A1 (en) Method of taking a physiological sample as well as skin puncturing element, test strip and apparatus for determining concentration of analyte in a physiological sample
WO2005112742A3 (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
EP1318399A3 (en) Passive sample detection to initiate timing of an assay
EP1447665A3 (en) Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method
DK1077636T3 (en) Signal processing for measurement of physiological analytes
WO2005003732A3 (en) Diagnostic test for analytes in a sample
WO2003040728A3 (en) Method and apparatus for the determination of glucose
DE60317422D1 (en) Mediator stabilizing compound and methods of use for detection of electrochemical analytes
MXPA02007420A (en) Methods and devices for use in analyte concentration determination assays.
EP1221620A3 (en) Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity
WO2001073114A3 (en) Reagents and methods for detecting a reduced cofactor
GR1004071B (en) Simultaneous analysis of blood samples and evaluation of blood content (hemoglobin)
WO2002059600A3 (en) Analyte detection
CA2024052A1 (en) Enzymatic method for determining analyte concentrations
WO1998046993A3 (en) Method for diagnosing cancer by measuring the presence of creatine kinase inhibitor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 32991/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1020027005917

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2001905073

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2388283

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 149665

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2002 2002113055

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/834/CHE

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/005798

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 018033369

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 1020027009675

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 2001 555862

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV2002-2945

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020027009675

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1020027005917

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001905073

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2002-2945

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 32991/01

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1020027009675

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 2001905073

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001905073

Country of ref document: EP